beta-D-GlcpNAc-(1->6)-alpha-D-Glcp-(1->2)-D-Glcp

Term ID

CHEBI:148222

Synonyms

2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)-alpha-D-gluco-hexopyranosyl-(1->2)-D-gluco-hexopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-alpha-D-glucopyranosyl-(1->2)-D-glucopyranose
GlcNAc(b1-6)Glc(a1-2)Glc
N-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(3R,4S,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]oxan-3-yl]acetamide

Definition

An amino trisaccharide consisting of 2-acetamido-2-deoxy-β-D-glucopyranose, α-D-glucopyranose and D-glucopyranose residues joined in sequence by (1→6) and (1→2) glycosidic bonds.

References

glytoucan:G19817JF
kegg.glycan:G08699

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GlcpNAc-(1->6)-alpha-D-Glcp-(1->2)-D-Glcp

Phenotype where environments contain beta-D-GlcpNAc-(1->6)-alpha-D-Glcp-(1->2)-D-Glcp

Phenotype modified by environments containing beta-D-GlcpNAc-(1->6)-alpha-D-Glcp-(1->2)-D-Glcp

Phenotype affecting beta-D-GlcpNAc-(1->6)-alpha-D-Glcp-(1->2)-D-Glcp

Human Disease Model